Tetherin (THN) (Bst2/CD317) is an interferon-induced antiviral factor, active against human immunodeficiency virus (HIV) and other enveloped viruses (Jouvenet et al., 2009; Kaletsky et al., 2009; Mansouri et al., 2009; Neil et al., 2008; Sakuma et al., 2009; Van Damme et al., 2008 ). An unusual structure (a cytosolic amino terminus, an extracellular coiled-coil domain and a GPI-anchored carboxy terminus) lets it 'tether' enveloped virions to the cellular plasma membrane post-scission, preventing their release (Neil et al., 2008) . Tetherin restricts a range of retroviruses and has the potential to influence host range, since viruses have evolved specific countermeasures (Douglas et al., 2010) . As an enveloped virus that buds from lipid rafts (Scheiffele et al., 1999; Takeda et al., 2003) , influenza A virus (IAV) is a potential target for this antiviral defence. Recent reports indicate that tetherin affects the release of influenza virus like particles (VLPs), but not authentic virions of the human A/ Udorn/72 or WSN strains (Watanabe & Lamb, 2010; Yondola et al., 2011) . To determine if tetherin plays a role in restricting IAV and/or the cross-species transmission of influenza strains, we tested the sensitivity of a panel of IAV strains from a variety of hosts to human tetherin, utilizing matched pairs of cell lines engineered to express varying amounts of the protein.
First, human cervical carcinoma (HeLa) cells expressing endogenous tetherin or stably transfected with the known tetherin antagonist, HIV-1 Vpu (Neil et al., 2008; Van Damme et al., 2008) to reduce cell-surface tetherin expression were tested. To validate the cell lines, we transfected them with two HIV-1 strains lacking Vpu (HXB2 or pNL4.3 DVPU). Virus release was determined at 48 h by infecting TZM-bl reporter cells with supernatants and assaying Tat-induced reporter gene activity (which is directly proportional to the amount of infectious virions) as described previously (Neil et al., 2006; Wei et al., 2002) . As expected, the HeLa-Vpu cells rescued the growth of the Vpu-null strains of HIV-1, increasing the amount of virions released into the supernatant between three (HXB2) and four (pNL4.3)-fold compared with parental cells, with the latter reaching the same titre as the wild-type (WT) NL4.3 clone, indicating efficient complementation of the VPU deletion (Fig. 1a) ; a filamentous variant of PR8 containing Udorn segment 7 (MUd; Noton et al., 2007) ; human H1N1 A/USSR/77 (USSR); porcine H1N1 A/ Swine/Eng/453/06 (Swine/Eng); H3N8 equine strains A/eq/Newmarket/11/02 (N11) and A/Eq/Miami/63 (Miami); laboratory adapted H1N1 A/WSN/33 (WSN); and avian H5N3 A/Duck/Singapore/5/97 (Duck/Singapore) and H4N6 A/Duck/England/62 (Duck/England) strains (Thompson et al., 2006) . Infections were performed as before (Bruce et al., 2010) , except that trypsin was omitted from viral growth media to avoid tetherin proteolysis. First, intracellular nucleoprotein (NP) accumulation was examined by Western blotting to assess infection levels. It appeared unlikely that tetherin interfered with early replication steps, as NP levels varied only between viral strains, not significantly between cell lines (Fig. 1b) . To assess virus replication, 1 mg trypsin S w i n e / E n g C a m P R 8 
ml 21 was added post-harvest and titres were measured by plaque assay (Hutchinson et al., 2008) . Different IAV strains replicated to varying extents, and while there was a general trend for the HeLa-Vpu cells to produce slightly more virus than the parentals, the effect was modest, generally around twofold (Fig. 1a) . This trend was also not universal, as Duck/ England grew better in parental than HeLa-Vpu cells. Nor was there any obvious correlation between host species of the IAV strain and its response to modulating tetherin levels.
To further test IAV sensitivity to tetherin, we repeated the experiments in human epithelial colorectal adenocarcinoma (Caco-2) cells; a parental line that expressed high levels of endogenous tetherin, and a derivative [Caco-2(2)THN] in which tetherin was stably knocked down (Rollason et al., 2009) . Validation was performed by infecting the cell lines with VSV-G pseudotyped NL4.3 WT or DVPU HIV at an m.o.i. of 0.5 and titrating the supernatants as before. The WT construct released similar quantities of virus from both cell types, while the Caco-2(2)THN cells released threefold more NL4.3DVPU HIV-1 than the parental Caco-2 cell line ( Fig. 1c) , indicating partial complementation of the Vpu(2) defect by suppressing tetherin expression. This partial restoration could potentially result from only a moderate reduction in tetherin levels and/or reflect other functions of VPU necessary for efficient particle formation that are not compensated for by removing tetherin. However, the knockdown of tetherin expression in the Caco-2(2)THN cells was apparently efficient as judged by Western blot analysis, showing readily detectable tetherin in the parental cells, but only trace quantities in the Caco-2(2)THN cells (Fig. 1d) . Next, these cells were infected with IAV, including filamentous (Udorn, PR8 MUd) or non-filamentous (Cam PR8, RG PR8) viruses, and viruses lacking the M2 [V7-T9 (Hutchinson et al., 2008) ] or NS1 proteins (in which position Cys13 of NS1 was mutated to a stop codon, while leaving NS2 unaltered). Again, the IAV strains grew to differing levels, with RG PR8 replicating the best and Udorn most poorly, but without notable differences between cell lines (Fig. 1c) . In every case, virus production was slightly (1.5-3-fold) higher in cells expressing normal levels of tetherin, a reversal of the trend observed in HeLa-Vpu cells.
As initial reports of tetherin restriction showed dramatic clustering of virions at the plasma membrane (Neil et al., 2008) , we used scanning electron microscopy to examine IAV budding in the presence and absence of tetherin. Cells were infected with PR8 as above and fixed at 16 h postinfection (p.i.) as described previously (Bruce et al., 2010) . Microvilli were observed on all mock-infected cell lines (Fig. 2a, b) . Spherical~100 nm diameter virions were scattered across the surface of PR8-infected HeLa and HeLa-Vpu cells (Fig. 2a, lower panels) , similar to previous reports (Bruce et al., 2010) . However, no notable difference in the numbers or morphology of virus particles on the HeLa versus HeLa-Vpu cells was seen. The surfaces of infected Caco-2 cells were profusely decorated with virus (Fig. 2b, middle panels) and the majority of budding PR8 virions were seen on microvilli-like projections extending away from the cell, forming cactus-like arrays. Again, no difference in IAV budding from Caco-2 or Caco-2(2)THN cells was apparent. Along with the titre data, this suggests that tetherin does not play a major role in preventing the release of authentic IAV.
Since tetherin plays a role in linking lipid rafts to the subapical actin cytoskeleton in polarized cells (Rollason et al., 2009) and intact cortical actin is required for filamentous influenza virion production Simpson-Holley et al., 2002) , we were curious to see if Caco-2 cells lacking tetherin would support filamentous budding. Following infection of Caco-2 or Caco-2(2)THN cells with MUd, long filamentous virions were observed protruding from both cell types (Fig. 2b, lower panels) . Thus, tetherin is not required for filamentous virion formation.
As multiple viruses counteract tetherin by removing it from the plasma membrane (Le Tortorec & Neil, 2009; Mansouri et al., 2009; Van Damme et al., 2008) , we tested if IAV had evolved a similar strategy, to explain its apparent insensitivity. Fluorescently activated cell sorting was used to examine surface tetherin levels of HeLa or HeLa-Vpu cells in response to infection. Cells (16 h p.i.) were washed in PBS, detached with 5 mM EDTA, labelled with anti-tetherin (H00000684-M02; Abnova) and anti-PR8 virus (Amorim et al., 2007) followed by fluorescently conjugated secondary antibodies (Invitrogen) before fixation in 4 % paraformaldehyde. Uninfected HeLa cells expressed easily detectable surface tetherin levels (Fig. 1e, top panel) , approximately Influenza is not restricted by tetherin 1 log 10 above the secondary antibody background. Tetherin levels were markedly lower in cells expressing HIV-1 Vpu. Amalgamated geometric means from independent experiments showed that HeLa-Vpu cells expressed~60 % less cell surface tetherin than HeLa cells (Fig. 1f) . After PR8 infection, both cell lines labelled similarly for surface haemagglutinin (HA) (Fig. 1e, lower panel) . However, infection did not grossly alter the levels of cell surface tetherin ( Fig. 1e ; compare shaded histograms to dashed lines); rather than decreasing (as predicted by the Vpu-like antagonist hypothesis) there was a small (~30 %, Fig. 1f ) increase in surface labelling after IAV infection. A smaller increase (~10 %) in the levels of cell surface tetherin was observed on HeLa-Vpu cells after PR8 infection, as well as after infection with the filamentous MUd strain (Fig. 1f) .
To examine the subcellular localization of tetherin relative to sites of influenza budding, surface tetherin and HA localization in the Caco-2 cell lines were probed using immunofluorescence and confocal microscopy in mockand Udorn-infected cells. Anti-tetherin (88523; Abcam) strongly labelled the surface of both mock and infected Caco-2 cells, but showed little reactivity with the Caco-2(2)THN cells (Fig. 3a) . Individual cells showed variable tetherin levels, although as with the HeLa cells, this did not change notably after infection (Fig. 3a) . Infected, but not uninfected cells, labelled strongly with an anti-H3 antibody (anti-X31). High magnification images (Fig. 3a, inset) of Caco-2 cells showed that surface tetherin and viral HA distributed in punctate patterns that overlapped substantially. Udorn produced filamentous virions in both cell types, though these were best visualized projecting away from the plasma membrane by orthogonal sectioning (Fig.  3b) . Strikingly, co-localization of HA and tetherin did not extend to viral filaments, with tetherin labelling restricted to the plasma membrane (Fig. 3b) , suggesting its exclusion from the virus structure. This is in agreement with a previous finding that a truncated form of tetherin is excluded from released virions (Watanabe et al., 2011) .
Overall, we found that IAV is broadly insensitive to human tetherin, including human, avian, swine and equine strains with a variety of HA and neuraminidase (NA) subtypes. One could argue that the modest increases (~twofold) seen for most IAV strains in the tetherin-depleted HeLa cells suggests a slight sensitivity, but this was not mirrored in the Caco-2 cells, which showed the opposite trend. Since tetherin knockdown was very efficient in the Caco-2 cells, and far greater replicative differences were seen between different IAV strains than for any strain in the different cell lines, we suggest that tetherin does not play a significant role in restricting IAV. Although we cannot exclude the possibility that sensitive strains exist, our data do not support the hypothesis that tetherin contributes significantly to the barrier to zoonotic IAV infection, in contrast to its postulated role for primate lentiviruses. Our data extend a recent report that replication of two human IAV strains were unaffected by tetherin (Watanabe et al., 2011) . These authors found that in contrast, IAV VLP release was sensitive, and suggested that NS1 (missing from VLPs) might function as an antagonist. Our results do not support this theory, as Caco-2 cells infected with a virus lacking NS1 produced no less virus than those lacking tetherin. By the same logic, neither is the viral M2 protein required for tetherin antagonism, as the M2-null V7-T9 virus showed no tetherin-specific growth defect. A separate report indicated that tetherin restricts the release of VLPs derived solely from NA (Yondola et al., 2011) . The authors suggested that the failure of some subtypes of NA (including N2 from Udorn) to form VLPs was due to their inability to antagonize tetherin. However, in authentic virus infection, Udorn NA does not confer tetherin sensitivity. More broadly, we tested viruses with five of the nine NA subtypes (N1-3, 6 and 8) and found them to be insensitive to tetherin. We suspect that the difference between virus budding and VLP formation lies in the difference between authentic virion structure and a cell-derived vesicle that happens to contain virus proteins, given that all IAV membrane-associated proteins have been found to be individually released from transfected cells (Chen et al., 2007; Gó mez-Puertas et al., 2000; Rossman et al., 2010; Yondola et al., 2011) .
Nevertheless, the different response of authentic virus and VLPs to tetherin is intriguing. If IAV does possess a specific antagonist, its mechanism is subtle and does not appear to involve bulk destruction of tetherin or its removal from the cell surface. Thus, we prefer the hypothesis that influenza's mode of budding confers a general insensitivity to tetherin. We initially hypothesized that filamentous virions (which can reach 30 mm in length) might help the virus evade tetherin, by keeping both ends of a tetherin dimer in the same (i.e., viral) membrane. However, no selective difference in sensitivity was seen for spherical viruses (e.g. PR8, Miami) versus filamentous strains (e.g. PR8 MUd or Udorn). Our current hypothesis is that IAV excludes tetherin from budding virus, despite its close proximity to surface HA. Although IAV particles do contain host proteins, these are at low levels (Shaw et al., 2008) . It is possible that this exclusion, perhaps mediated by the organized nature of the virus particle, prevents tetherin from accessing the nascent particle. Conversely, the less organized nature of a VLP may confer tetherin sensitivity by allowing it into the segregating vesicular structure. It would be interesting to test the sensitivity of viruses with deletions of the HA and NA cytosolic tails, as these mutations apparently disrupt the organized nature of the virion (Jin et al., 1997) .
